# Pleno

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pleno

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.plenoinc.com
- Total disclosed funding: $64M
- Latest round: Series B (Dec 12, 2024)
- Investors on record: 4

## About

Based in California, US, and founded in 2017 by Pieter van Rooyen (CEO), Pleno Inc is a biotechnology research company that provides biological target detection and diagnostic solutions for clinical testing and biomedical research. In December 2024, Pleno Inc. raised USD 25 million in series B funding from returning investors Deerfield Management, Foresite Capital, and Medical Excellence Capital, with participation from other unspecified investors. The company employs its proprietary Hypercoding technology that uses telecommunications signal-processing techniques to deliver targeted biological information on DNA, RNA, methylation, and proteomic content, enabling a wide range of applications ranging from screening and detection to diagnostics, prognostics, and other diagnostic and therapeutic purposes.

## Funding rounds

- Series B, Dec 12, 2024, $25M — Foresite Capital, Deerfield Management, Medical Excellence Capital
- Series A, Oct 7, 2022, $15M — Foresite Capital, Deerfield Management
- Series A, Aug 15, 2022, $24M — Alexandria Venture Investments, Medical Excellence Capital

## Investors

- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Medical Excellence Capital (https://capitalatlas.ai/funds/medical-excellence-capital) — Series A, Series B
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series A, Series B
- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series A, Series B